Jade Biosciences (JBIO) Enterprise Value (2020 - 2026)
Jade Biosciences posted quarterly Enterprise Value of -$311.3 million for Q1 2026, down 187.73% year-on-year from $354.8 million in Q1 2025, and up 7.39% on a QoQ basis from -$336.2 million in Q4 2025.
Jade Biosciences (JBIO) has 7 years of Enterprise Value data on file, last reported at -$311.3 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 187.73% year-over-year to -$311.3 million; the trailing twelve-month figure through Mar 2026 stood at -$311.3 million (down 187.73% YoY), and the FY2025 full-year result was -$336.2 million, down 384.48% from the prior year.
- Enterprise Value for Q1 2026 stood at -$311.3 million, up from -$336.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$69.4 million in Q4 2024 and bottomed at -$336.2 million in Q4 2025.
- The 5-year median for Enterprise Value is -$142.6 million (2022), against an average of -$159.2 million.
- The widest annual swing landed in 2024, when Enterprise Value jumped 43.33%; it then tumbled 384.48% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$129.2 million in 2022, then grew by 5.25% to -$122.4 million in 2023, then surged by 43.33% to -$69.4 million in 2024, then sank by 384.48% to -$336.2 million in 2025, then climbed by 7.39% to -$311.3 million in 2026.
- The last three Enterprise Value figures came in at -$311.3 million (Q1 2026), -$336.2 million (Q4 2025), and -$198.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | -311.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -311.30 Mn |
| Dec 31, 2025 | -336.16 Mn |
| Sep 30, 2025 | -198.91 Mn |
| Jun 30, 2025 | -220.90 Mn |
| Mar 31, 2025 | -108.19 Mn |
| Dec 31, 2024 | -69.39 Mn |
| Sep 30, 2024 | -146.32 Mn |
| Jun 30, 2024 | -104.20 Mn |
| Mar 31, 2024 | -99.33 Mn |
| Dec 31, 2023 | -122.44 Mn |
| Sep 30, 2023 | -135.20 Mn |
| Jun 30, 2023 | -150.10 Mn |
| Mar 31, 2023 | -118.93 Mn |
| Dec 31, 2022 | -129.22 Mn |
| Sep 30, 2022 | -142.58 Mn |
| Jun 30, 2022 | -151.99 Mn |
| Mar 31, 2022 | -161.07 Mn |
| Dec 31, 2021 | -167.38 Mn |
| Sep 30, 2021 | -180.90 Mn |
| Jun 30, 2021 | -55.15 Mn |
| Dec 31, 2020 | 7.71 Mn |
| Jun 30, 2020 | -186.15 Mn |